VIDEO: Sustainable funding of antibiotic development
WASHINGTON – Kevin Outterson, JD, LLM, delivered a keynote fireside chat during the World Anti-Microbial Resistance Congress that discussed novel pull incentives to develop antibiotics in the United States.
“One of the things I think people don’t know enough about is how important antibiotics are to everything else in the health care system,” said Outterson, a professor of law at Boston University and executive director of CARB-X. “But we’re not paying for them in a sustainable fashion.”
CARB-X, which is part of Boston University, is a global public-private partnership dedicated to accelerating antibacterial research. It is funded by the Biomedical Advanced Research and Development Authority (BARDA) and other groups.
Outterson recently published a research article that discusses some of the pull incentives being used to pay for antibiotics.